Top Journalists in Health Care
Brianna Abbott The Wall Street Journal
Health reporter at The Wall Street Journal focused on the treatment and prevention of disease with a special emphasis on oncology and public-health guidance. Specialties: Public health, cancer, screening guidelines, CDC/USPSTF recommendations.
Pam Belluck The New York Times
Veteran New York Times health and science writer known for deep explanatory reporting on COVID-19, brain health, and complex medical ethics. Specialties: Infectious diseases (including long COVID), neuroscience, mental health, reproductive health.
Helen Branswell STAT
STAT’s infectious-diseases correspondent and a leading voice on outbreaks from SARS to COVID-19, recognized with major journalism awards for pandemic coverage. Specialties: Infectious diseases, outbreak preparedness, vaccines, global health.
Caroline Chen ProPublica
ProPublica investigative reporter whose work on hospitals, federal health agencies, and pandemic inequities has earned national honors including a Livingston Award. Specialties: Hospitals, public health systems, FDA/CDC accountability, patient safety.
Rachel Cohrs Zhang STAT
STAT’s chief Washington correspondent (D.C. Diagnosis author) covering how politics and business shape federal health policy. Specialties: Congress and health policy, FDA, drug pricing, D.C. health politics.
Dan Diamond The Washington Post
Washington Post national reporter known for accountability scoops on federal health leaders and policy, previously at Politico. Specialties: Federal health agencies (HHS, CDC, FDA), health politics, investigations.
Nicholas Florko STAT
STAT reporter examining how corporate decisions and federal regulators shape public health, after years covering FDA and pricing in D.C. Specialties: FDA regulation, drug pricing, vaping/tobacco, commercial determinants of health, Hill oversight.
Christina Jewett The New York Times
Investigative reporter at The New York Times who covers the FDA and medical product safety, with a track record of high-impact accountability reporting. Specialties: FDA and drug/device safety, hospital quality, investigations.
Sarah Kliff The New York Times
Investigative reporter at The New York Times and one of the country’s foremost health-policy journalists, noted for landmark reporting on medical billing. Specialties: Health costs and billing, ACA policy, federal health programs, investigations.
Robert Langreth Bloomberg News
Bloomberg health reporter-at-large covering the business and science of medicines, from obesity and Alzheimer’s drugs to FDA actions. Specialties: Pharmaceutical industry, drug development, obesity and Alzheimer’s therapeutics, FDA news.
Noam N. Levey KFF Health News
Senior correspondent at KFF Health News leading national reporting on Americans’ medical debt and the U.S. coverage system. Specialties: Medical debt, insurance markets, health equity, Medicaid/ACA policy.
Peter Loftus The Wall Street Journal
Wall Street Journal reporter and author who covers the drug and device industries and the business of biopharma. Specialties: Pharmaceuticals, medical devices, vaccine industry, biotech finance.
Apoorva Mandavilli The New York Times
New York Times reporter on global health and infectious diseases and founding editor-in-chief of Spectrum, focused on medical science reporting. Specialties: Global health, infectious diseases, vaccines and epidemiology.
Anna Wilde Mathews The Wall Street Journal
WSJ reporter who covers health insurance and reimbursement policy, frequently breaking news on payer strategy and regulation. Specialties: Health insurers and reimbursement, payer policy, Medicare Advantage.
Alice Miranda Ollstein POLITICO
POLITICO health-care reporter on the Hill, with a strong focus on reproductive policy and federal health legislation. Specialties: Capitol Hill health policy, reproductive health, Medicaid/ACA politics.
Rebecca Robbins The New York Times
New York Times reporter covering prescription drugs and the life-sciences industry, including vaccine and biotech developments. Specialties: Pharmaceuticals, vaccines, biotech business and regulation.
email | phone/SMS/Signal/WhatsApp | X
Rachel Roubein The Washington Post
Washington Post health-care reporter focused on the FDA; previously anchored The Health 202 newsletter (now Health Brief). Specialties: Food and Drug Administration, vaccines, federal health policy.
Margot Sanger-Katz The New York Times
Domestic correspondent at The New York Times writing for The Upshot on U.S. health policy and its politics, with a signature data-explainer style. Specialties: Health policy and economics, ACA/Medicaid/Medicare, data-driven analysis.
Ed Silverman STAT
Senior writer and Pharmalot columnist at STAT with decades covering the pharmaceutical industry and winners of major business journalism awards. Specialties: Pharma business and policy, drug pricing, FDA oversight; Pharmalot columnist.
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.